Opaleye Management disposes of 28,315 Eton Pharma shares worth $1.06 million
ETON•Opaleye Management reports sale of Eton Pharmaceuticals shares
- Opaleye Management, a 10% owner of Eton Pharmaceuticals, reported selling 28,315 common shares on July 14.
- Sales were priced at a weighted average of $37.54 per share.
- Beneficial ownership fell to 2.67 million shares held via Opaleye, L.P.
- Separate managed-account holdings declined to 40,000 shares.
